arrow
返回
X

Xiubao Ren

nankai university

60H指数
456论文数
1.5W被引数
收录论文 149
发表时间
Dendritic cell centric nanoengineering couples antigen acquisition and STING activation for cancer immunotherapy树突状细胞中心纳米工程将抗原获取与STING激活耦合用于癌症免疫疗法
err2026-09-07
err0
errOAAI
errShuting Xiang; Shanshan Ma; Tuzhi Xu; Wenwen Yu; Jiefu Wang; Xin You; Mengjia Chai; Xiaohu Wang; Xiaoliang Wang; Junmei Zhang; Junjia Liu; Xiubao Ren; Weijie Song; Tingting Qin; Suxin Li; Jian Wang
err分享
err收藏
Advancing CIK cell immunotherapy: highlights from the second international conference on DC-CIK and CAR-CIK approaches推进CIK细胞免疫治疗:第二国际会议关于DC-CIK和CAR-CIK方法的亮点
err2025-11-03
err0
errOAAI
errSharma, Amit; Sangiolo, Dario; Rosato, Antonio; Pu, Jingjing; Hou, Jian; Tettamanti, Sarah; Serafini, Marta; Fenix, Kevin Aaron; Introna, Martino; Rambaldi, Alessandro; Ren, Xiubao; Schmidt-Wolf, Ingo G. H.
err分享
err收藏
First-line benmelstobart plus anlotinib versus sunitinib in advanced renal cell carcinoma (ETER100): a multicentre, randomised, open-label, phase 3 trial一线贝美替尼联合阿尼洛替尼与舒尼替尼对比治疗晚期肾细胞癌(ETER100):一项多中心、随机、开放标签、III期临床试验
err2025-09-01
err0
PREAI
errAiping Zhou; Pengfei Shen; Juan Li; Wang Qu; Zengjun Wang; Xiubao Ren; Yuan Li; Shusuan Jiang; Gang Li; Yu Zeng; Weijun Qin; Jin Wu; Peng Chen; Fangjian Zhou; Hongqian Guo; Zhigang Ji; Yongquan Wang; Zhisong He; Jitao Wu; Benkang Shi; Lian Liu; Xudong Yao; Lulin Ma; Ziling Liu; Xin Gou; Bin Fu; Shaogang Wang; Kui Jiang; Tie Chong; Xinhua Tu; Xu Zhang; Dexin Yu; Mulati Rexiati; Xueyi Xue; Jing Fei; Jianghou Wan; Liqun Jia; Yi He; Tongjian Cui; An-Qi Yang; Jun Guo; Xinan Sheng
err分享
err收藏
Advances in adoptive cellular immunotherapy and therapeutic breakthroughs in multiple myeloma过继性细胞免疫治疗进展及多发性骨髓瘤治疗突破
err2024-10-28
err0
errOAAI
errPu, Jingjing; Liu, Ting; Sharma, Amit; Jiang, Liping; Wei, Feng; Ren, Xiubao; Schmidt-Wolf, Ingo G. H.; Hou, Jian
err分享
err收藏
Association of concomitant H1 antihistamine and immune checkpoint inhibitor therapy on survival outcome and safety in patients with advanced primary lung cancer: a cohort study
err2024-10-01
err0
errOAAI
errZhang, Wei-Hong; Li, Bing-Xue; Ma, Chen-Xi; Wang, Jian; Yang, Fan; Xiong, Yan-Juan; Li, Shu-Zhan; Zhang, Jia-Li; Du, Wei-Jiao; Hui, Zhen-Zhen; Shen, Meng; Zhou, Li; Li, Run-Mei; Tian, Xiao; Han, Ying; Ren, Bao-Zhu; Ichiki, Yoshinobu; Lee, Sang Chul; Zhang, Xin-Wei; Cao, Shui; Ren, Xiu-Bao; Liu, Liang
err分享
err收藏
err分享
err收藏
Intratumor tertiary lymphatic structure evaluation predicts the prognosis and immunotherapy response of patients with colorectal cancer (vol 15, 1302903, 2024)
err2024-06-14
err0
errOAAI
errFeng, Huijing; Zhang, Siyuan; Zhou, Qiuru; Han, Fei; Du, Gang; Wang, Lin; Yang, Xuena; Zhang, Xiying; Yu, Wenwen; Wei, Feng; Hao, Xishan; Ren, Xiubao; Zhao, Hua
err分享
err收藏
Phosphoglycerate mutase 1 promotes breast cancer progression through inducing immunosuppressive M2 macrophages
err2024-05-15
err1
PREAI
errZhang, Dong; Wang, Min; Ma, Shiya; Liu, Min; Yu, Wenwen; Zhang, Xiying; Liu, Ting; Liu, Shaochuan; Ren, Xiubao; Sun, Qian
err分享
err收藏
A phase II study of efficacy and safety of the MEK inhibitor tunlametinib in patients with advanced NRAS-mutant melanomaMEK抑制剂tunlametinib在晚期NRAS突变型黑色素瘤患者中的疗效和安全性的II期研究
err2024-05-01
err2
PREAI
errWei, Xiaoting; Zou, Zhengyun; Zhang, Weizhen; Fang, Meiyu; Zhang, Xiaoshi; Luo, Zhiguo; Chen, Jing; Huang, Gang; Zhang, Peng; Cheng, Ying; Liu, Jiwei; Liu, Jiyan; Zhang, Junping; Wu, Di; Chen, Yu; Ma, Xiaobiao; Pan, Hongming; Jiang, Renbing; Liu, Xinlan; Ren, Xiubao; Tian, Hongqi; Jia, Zhongwei; Guo, Jun; Si, Lu
err分享
err收藏
A retrospective analysis of mature T- and NK-cell lymphomas
err2024-03-27
err1
errOAAI
errJia, Junlei; Wang, Xiaohui; Song, Zheng; Meng, Shen; Fei, Yue; Yu, Jingwei; Liu, Xia; Han, Xue; Li, Lanfang; Qiu, Lihua; Qian, Zhengzi; Zhou, Shiyong; Gong, Wenchen; Meng, Bin; Ren, Xiubao; Wang, Xianhuo; Zhang, Huilai
err分享
err收藏
err分享
err收藏